Altay Therapeutics, Inc., 2026-10-02
An SEC Form D private-offering notice from San Carlos, CA, a $45,067,885 filer-stated offering target in Biotech. Filed 2026-10-02. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotech developing oral small molecule inhibitors of transcription factors, including a lead DUX4 inhibitor for facioscapulohumeral muscular dystrophy and a STAT3 inhibitor program for cancer and inflammatory disease
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- BAM Life, Inc., 2026-10-05, $500K, Los Altos, CA
- Renovare Therapeutics, Inc., 2026-10-02, $1M, Boulder, CO
- Henshin AI, Inc., 2026-10-05, $15K, San Jose, CA
- CAD Therapeutics, Inc., 2026-10-02, $10M, New York, NY
- ZymoChem, Inc., 2026-10-02, $34.2M, San Leandro, CA
- Superstorefront Inc., 2026-10-02, $350K, Sacramento, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.